Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats

BACKGROUND: Epidemic projections and public health policies addressing Coronavirus disease (COVID)-19 have been implemented without data reporting on the seroconversion of the population since scalable antibody testing has only recently become available. METHODS: We measured the percentage of severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Nesbitt, Daniel J., Jin, Daniel P., Hogan, Joseph W., Yang, Jenny, Chen, Haidee, Chan, Philip A., Simon, Melissa J., Vargas, Matthew, King, Ewa, Huard, Richard C., Bandy, Utpala, Hillyer, Christopher D., Luchsinger, Larry L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386143/
https://www.ncbi.nlm.nih.gov/pubmed/34433423
http://dx.doi.org/10.1186/s12879-021-06438-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386143/
https://www.ncbi.nlm.nih.gov/pubmed/34433423
http://dx.doi.org/10.1186/s12879-021-06438-4

Ejemplares similares